Your browser doesn't support javascript.
The outcome ofancy. COVID-19 in patients with hematological malign
Yigenoglu, Tugce N; Basci, Semih; Dal, Mehmet S; Korkmaz, Serdal; Turgut, Burhan; Altuntas, Fevzi.
  • Yigenoglu TN; Department of Hematology and Bone Marrow Transplantation Center, Ankara Oncology Training and Research Hospital, University of Health Sciences, Ankara, Turkey.
  • Basci S; Department of Hematology and Bone Marrow Transplantation Center, Ankara Oncology Training and Research Hospital, University of Health Sciences, Ankara, Turkey.
  • Dal MS; Department of Hematology and Bone Marrow Transplantation Center, Ankara Oncology Training and Research Hospital, University of Health Sciences, Ankara, Turkey.
  • Korkmaz S; Department of Hematology, Kayseri Training and Research Hospital, University of Health Sciences, Kayseri, Turkey.
  • Turgut B; Division of Hematology, Department of Internal Medicine, School of Medicine, Namik Kemal University, Tekirdag, Turkey.
  • Altuntas F; Department of Hematology and Bone Marrow Transplantation Center, Ankara Oncology Training and Research Hospital, University of Health Sciences, Ankara, Turkey.
J Med Virol ; 93(3): 1255, 2021 03.
Article in English | MEDLINE | ID: covidwho-1100896

Full text: Available Collection: International databases Database: MEDLINE Main subject: Hematologic Neoplasms / COVID-19 Type of study: Observational study / Prognostic study Topics: Long Covid Limits: Humans Language: English Journal: J Med Virol Year: 2021 Document Type: Article Affiliation country: Jmv.26607

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Hematologic Neoplasms / COVID-19 Type of study: Observational study / Prognostic study Topics: Long Covid Limits: Humans Language: English Journal: J Med Virol Year: 2021 Document Type: Article Affiliation country: Jmv.26607